GAMBARAN KEPATUHAN MINUM OBAT PADA PASIEN DIABETES MELITUS TIPE 2 DENGAN PENYAKIT PENYERTA HIPERTENSI DI WILAYAH KERJA PUSKESMAS SANGGAU
Abstrak
The prevalence of type 2 diabetes and hypertension comorbidity is very high,exacerbating each other and increasing the risk of complications. Medication adherence is one of the factors that determine the success of pharmacological therapy for both chronic diseases. Complex pharmacological therapy increases the risk of polypharmacy, thereby increasing the potential for Drug-Related Problems (DRPs) and often reducing medication adherence. The aim of this study is to describe the level of medication adherence in patients with type 2 diabetes and comorbid hypertension, analyze associated factors such as duration of illness, number and frequency of medication intake. This study is a descriptive analytical study with a cross-sectional design. The sample consisted of 47 patients with type 2 diabetes and hypertension. Primary data were collected using the MMAS8 questionnaire, and secondary data were obtained from medical records. The results showed that medication adherence was low in 57.4% of patients, moderate in 27.7%, and high in 14.9%. There was a significant association between medication adherence with the number of medications (p = 0.020) and medication frequency (p = 0.001), while disease duration was not significantly associated (p = 1.000). Medication adherence among patients with type 2 diabetes mellitus and hypertension was low, influenced by the number of medications and frequency of administration.
Penulis
Cara Mengutip
Please find the rights and licenses in Jurnal Sabdariffarma. By submitting the article/manuscript of the article, the author(s) agree with this policy. No specific document sign-off is required.
- License
The non-commercial use of the article will be governed by the Creative Commons Attribution license as currently displayed on Creative Commons Attribution-Share Alike 4.0 International License.
- Author(s)' Warranties
The author warrants that the article is original, written by stated author(s), has not been published before, contains no unlawful statements, does not infringe the rights of others, is subject to copyright that is vested exclusively in the author and free of any third party rights, and that any necessary written permissions to quote from other sources have been obtained by the author(s).
- User Rights
Sabdariffarma's spirit is to disseminate articles published are as free as possible. Under the Creative Commons license, Sabdariffarma permits users to copy, distribute, display, and perform the work for non-commercial purposes only. Users will also need to attribute authors and Sabdariffarma on distributing works in the journal and other media of publications.
- Rights of Authors
Authors retain all their rights to the published works, such as (but not limited to) the following rights;
- Copyright and other proprietary rights relating to the article, such as patent rights,
- The right to use the substance of the article in own future works, including lectures and books,
- The right to reproduce the article for own purposes,
- The right to self-archive the article,
- The right to enter into separate, additional contractual arrangements for the non-exclusive distribution of the article's published version (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal (Jurnal Sabdariffarma).
- Co-Authorship
If the article was jointly prepared by more than one author, any authors submitting the manuscript warrants that he/she has been authorized by all co-authors to be agreed on this copyright and license notice (agreement) on their behalf, and agrees to inform his/her co-authors of the terms of this policy. Sabdariffarma will not be held liable for anything that may arise due to the author(s) internal dispute. Sabdariffarma will only communicate with the corresponding author.
- Royalties
Being an open accessed journal and disseminating articles for free under the Creative Commons license term mentioned, author(s) aware that Sabdariffarma entitles the author(s) to no royalties or other fees.
- Miscellaneous
Sabdariffarma will publish the article (or have it published) in the journal if the article’s editorial process is successfully completed. Sabdariffarma's editors may modify the article to a style of punctuation, spelling, capitalization, referencing and usage that deems appropriate. The author acknowledges that the article may be published so that it will be publicly accessible and such access will be free of charge for the readers as mentioned in point 3.
Privacy Statement
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.